reference/30160211

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/30160211

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Comparative Study\|Journal Article\|Multicenter Study\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	906
issn	0140-6736
issueIdentifier	9489
pageRange	895-906
publicationName	Lancet (London, England)
startingPage	895
bibliographicCitation	Dahlöf B, Sever PS, Poulter NR, Wedel H, Beevers DG, Caulfield M, Collins R, Kjeldsen SE, Kristinsson A, McInnes GT, Mehlsen J, Nieminen M, O'Brien E, Ostergren J; ASCOT Investigators. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet. 2005 Sep;366(9489):895–906. doi: 10.1016/s0140-6736(05)67185-1. PMID: 16154016.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_20659d307a9b716fcf21e69cfdbf695b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2f14c23f68c2b6da4be501a66704325e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d535878626cc8c5ea77a6add142c44b9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cf05771e203c3cb898b8f7ad179ae7f0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-9295-3594 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_20ebb78cacdb67f1606514cb6bc0e7ac http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_45285517f5e3e8044b02ed388d566916 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dfd6955ca4e0b88ed7eb8e6fd147b35e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ca4f3705bf7a913e0b964a3a8bceca52 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2e59ecb416d59702ad08d69ed0223ffc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7fddf7e917f944b09268d67e3f2f82f8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6f40a3c879d8f205f6c182fd4078d08d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_949efbb80d9ef0e3032002a6f6bddcbd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_58b94e3885f188061d905723846fd1ad http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_18f6c9e7a38a10c37faeeef1f541cd95
date	200509
identifier	https://pubmed.ncbi.nlm.nih.gov/16154016 https://doi.org/10.1016/s0140-6736%2805%2967185-1
isPartOf	https://portal.issn.org/resource/ISSN/0140-6736 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5470
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial
discusses	http://id.nlm.nih.gov/mesh/M0001900 http://id.nlm.nih.gov/mesh/M0003165 http://id.nlm.nih.gov/mesh/M0000495 http://id.nlm.nih.gov/mesh/M0129811 http://id.nlm.nih.gov/mesh/M0001207 http://id.nlm.nih.gov/mesh/M0002310 http://id.nlm.nih.gov/mesh/M0471877 http://id.nlm.nih.gov/mesh/M0026284 http://id.nlm.nih.gov/mesh/M0001456 http://id.nlm.nih.gov/mesh/M0006624
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D000959Q000008 http://id.nlm.nih.gov/mesh/D049993Q000008 http://id.nlm.nih.gov/mesh/D002121Q000008 http://id.nlm.nih.gov/mesh/D001539Q000008 http://id.nlm.nih.gov/mesh/D006973Q000188 http://id.nlm.nih.gov/mesh/D002318Q000517 http://id.nlm.nih.gov/mesh/D001794Q000187 http://id.nlm.nih.gov/mesh/D000319Q000008
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D002121Q000009 http://id.nlm.nih.gov/mesh/D003327Q000517 http://id.nlm.nih.gov/mesh/D004232 http://id.nlm.nih.gov/mesh/D017311Q000009 http://id.nlm.nih.gov/mesh/D017311Q000008 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D001262Q000009 http://id.nlm.nih.gov/mesh/D000806Q000008 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D004359 http://id.nlm.nih.gov/mesh/D006973Q000150 http://id.nlm.nih.gov/mesh/D012307 http://id.nlm.nih.gov/mesh/D001262Q000008 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D000319Q000009 http://id.nlm.nih.gov/mesh/D020913Q000008 http://id.nlm.nih.gov/mesh/D000959Q000009
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7181 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2720 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID107807 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7440 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2249 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8102 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5462222 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2162 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8135 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8564 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7347 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2315 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10602

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128203001 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128046748 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128585206 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129815624

Total number of triples: 87.